In hemochromatosis and other disorders associated with iron overload, a significant fraction of the total iron in plasma circulates in the form of low molecular weight complexes not bound to transferrin. Efficient and unregulated clearance of this form of iron by the liver may account for the hepatic iron loading and toxicity that characterize these diseases. We tested this possibility by examining the hepatic removal process for representative iron complexes in the single-pass perfused rat liver. Hepatic uptake of both ferrous and ferric 55Fe from ultrafiltered human serum was found to be highly efficient and effectively irreversible (single-pass extraction of 1 MM iron, 58-75%). Similar high efficiencies were seen for iron complexed to specific physiologic and nonphysiologic coordinators, including histidine, citrate, fructose, oxalate and glutamate, and tricine. Because of lower plasma flow rates, single-pass extraction of these iron complexes in vivo should be even greater. Autoradiography confirmed that most iron had been removed by parenchymal cells. Hepatic removal from Krebs-tricine buffer was saturable with similar kinetic parameters for ferrous and ferric iron (apparent K., 14-22 ,uM; V.,, 24-38 umol min-' g liver-'). These findings suggest that high levels of non-transferrin-bound iron in plasma may be an important cause of hepatic iron loading in iron overload states.
Introduction
Despite its potential for toxicity, iron is an essential cofactor in the metabolism of all mammalian cells. As a result, regulatory mechanisms have evolved that closely control the absorption and distribution of iron within the body. Most iron circulates tightly bound to transferrin, a plasma glycoprotein. Tissue uptake of this form of iron has been well-characterized, and seems to be regulated by the number of receptors for transferrin expressed on the cell surface (1) (2) (3) (4) . The uptake process mediated by these receptors typically removes <1% of the iron from plasma as it passes through the liver (5) .
In contrast, the uptake ofnon-transferrin-bound (NTB)' iron has received much less attention. NTB iron is defined as that iron in plasma that is not complexed by transferrin, and is thought to consist ofa mixture of iron complexes with ascorbate, carbonate, certain amino acids, carbohydrates, hydroxide, certain organic acids, and, to a lesser degree, plasma proteins such as albumin (6, 7) . In normal individuals, the plasma concentration of NTB iron is extremely small (7) (8) (9) . However, much higher concentrations have been reported in hemochromatosis (9) and transfusional iron overload (8) , possibly reflecting saturation of the binding capacity of transferrin. Ifthe hepatic uptake process for this form ofiron is both efficient and unregulated, high plasma levels of NTB iron could be the proximate cause of hepatic iron loading and toxicity in hemochromatosis and other iron overload states. To test this hypothesis, we studied the uptake of representative NTB iron complexes in the perfused rat liver.
Methods
Sources ofchemicals. Solution preparation and validation. The normal perfusion solution was a modified Krebs-Henseleit buffer containing 128 mM Na', 145 mM Cl-, 5.9 mM K+, 1.2 mM Mg", 2.5 mM Ca", 1.2 mM phosphate, 1.2 mM S04--, 11 .5 mM glucose, and 10 mM tricine base in deionized water, and was prepared daily from concentrated stocks. Solution pH was adjusted to 7.4 at 240C with 0.1 N HCI, resulting in a pH of 7.31 at 37°C. All solutions, except those containing ferrous iron, were equilibrated with 100% 02 at 37°C before use. Ferrous iron solutions were prepared using buffer that had been rendered anaerobic by vigorous bubbling with 100% N2 for at least 30 min and were kept under N2 during use. Ferric iron solutions were prepared by autooxidation of the corresponding ferrous solution under 100% 02. Assay of these solutions by the method ofBothwell et al. (1O) confirmed that oxidation to ferric iron was virtually complete within I min after addition ofoxygen, while ferrous iron solutions with and without ascorbate remained stable for at least 4 h. To assess the degree of aggregation of the iron in the perfusate solutions, we measured the initial rate of diffusion of ferrous and ferric iron across a cellulose membrane (2.5-cm diam, molecular weight cut off, 2,000 [Spectrum Medical Industries, Inc, Los Angeles, CA]) at 370C.
In these studies, 4 ml of tricine buffer was dialyzed against 160 ml of perfusate for 60 min and the ratio (R) of radioactivity inside the bag to that in the perfusate was determined for each concentration used in the perfusion experiments (1-60 gM). The half-life for equilibration was determined from the expression, t,2 = 60 min X log (0.5)/log (I -R). In human serum was prepared by ultrafiltration of fresh serum through a PM 30 membrane (Amicon Corp., Danvers, MA). To minimize iron binding, we acid-washed all glass containers (including test tubes), dried them thoroughly, and siliconized them by immersion in a solution of 5% dimethyldichlorosilane in toluene for 1 h. Glassware was rinsed in distilled water and dried before use.
Perfusion apparatus. Livers were perfused in a modified lucite cabinet (Air Control 0432112; Huntingdon Valley, PA) with humidified and independently thermoregulated upper and lower chambers. In this system (Fig. 1) 02, 5% C02) using gravity flow. The inferior vena cava was ligated above the renal veins and transected distally. The thorax was opened and a PE-205 polyethylene catheter secured in the superior vena cava through an incision in the right atrium. The liver was then carefully removed, placed on a nylon mesh to facilitate handling (80-mm diam with a central 10-mm hole and radial slit), and rinsed with warm saline. After temporary obstruction of the outflow catheter, the portal vein catheter was reconnected to the perfusion system containing 50 ml of 20% fluorocarbon emulsion pre-equilibrated with 95% 02, 5% CO2 in the recirculating mode (5 ml * min-'). The liver was lowered onto the perfusion platform (a 10-cm petri dish with a central opening) and the position of the inflow and out-flow catheters was carefully adjusted. The flow rate was then gradually advanced to 20-25 ml * min-' while monitoring the pressure for evidence of obstruction. Perfusion protocol. After a 30-min stabilization period during which the lung was gassed with pure 02 plus sufficient CO2 to maintain the perfusate pH at 7.4, the apparatus was switched to the single-pass mode and the bypass valve was set for direct flow of the perfusate from the pump to the liver. The liver was then perfused with oxygenated buffer for 4 min to wash out the fluorocarbon emulsion. During this period, the flow rate was advanced to -2.6 ml * min--g' liver and carefully measured by timed collection.
In most experiments, the liver was then perfused with a sequence of test solutions containing graded concentrations of ferrous or ferric iron (30 s each). Each test solution was followed with a 60-90-s wash with oxygenated perfusion buffer. The effluent stream was sampled after steady-state had been achieved (typically <25 s) and at intervals during the washout phase, using siliconized glass tubes (10 X 75 mm), each of which contained 25 Ml of 10% bovine albumin to further minimize binding of iron to the glass. Control experiments indicated that samples were stable for at least 3 h under these conditions. "Fe was quantitated in triplicate by scintillation counting in Dimilume (Packard Instruments, Inc.).
Data analysis. The rate of iron removal by the liver at steady-state (V) was calculated according to Eq. 1 below, where C is the concentration of iron in the entering perfusate, F is the flow rate (liters -min-'), E is the fraction of the iron extracted by the liver in a single pass, and W is the wet weight of the liver (g). Data for individual experiments were analyzed by nonlinear leastsquares curve fitting in which the uncertainty of each data point was assumed to be proportional to its magnitude (weighting power = 2). Models with up to two saturable uptake components with and without a nonsaturable uptake component were considered for representing the data. A single saturable uptake component was found to adequately account for the data. More complicated models did not result in a significant improvement in the fit and had large uncertainties in the derived parameters. Results for replicate studies were averaged. Statistical significance was assessed by use of the Student's I test.
This method of analysis assumes that each hepatocyte has a similar uptake capacity and is exposed to the same concentration of iron. However, since the hepatocytes are actually exposed to concentrations ofiron ranging from that entering the liver to that in the effluent stream, this is an oversimplification. Recalculation based on the effluent rather than the entering iron concentrations resulted in relatively small changes in the kinetic constants (apparent Km reduced -35% with no effect on the apparent V.). In this study, the uptake rate is related to the entering iron concentration, since this value is most often clinically available.
Microscopic studies. After selected experiments, livers were postperfused with iced 2.7% glutaraldehyde plus 0.8% paraformaldehyde and prepared for light and electron microscopy using standard methods. Loss of radioactivity during processing of the tissue was <5%. Thin sections (0.2 um) were coated with Kodak nuclear track emulsion NTB2, and developed in Kodak D-19 developer after a 4-8-week exposure period.
Results
Microscopy. Electron microscopy showed excellent preservation of detail with no evidence of toxicity, even after 30 min of perfusion with 1 gM ferrous iron (Fig. 2) . Ultrastructural features appeared completely normal. Light microscopy was normal, except for a slight widening of the sinusoidal spaces (Fig. 3) . This change appeared to result from replacement ofbicarbonate with tricine, since it was not seen in livers perfused with bicarbonate buffers alone.
Solution validation. Ferric iron was freely and equally diffusible at all concentrations used in these studies (Fig. 4) Because we were concerned that saturation of the hepatic iron storage capacity might occur at higher concentrations of iron (resulting in increased rates of iron efflux from the liver), iron concentrations were measured in the wash solution after each test solution. In all cases, efflux rates were negligible with respect to uptake rates, and calculations indicated that <1% of the total hepatic "Fe effluxed from the liver during a typical experiment. Similar saturation kinetics were seen when the sequence of perfusate solutions was reversed. Taken together, these results indicate that the liver remains viable for at least 15 min under the conditions ofthese experiments, and that each steadystate determination is effectively independent of previous determinations performed on the same liver.
Effect of transient anaerobiasis. As discussed previously, perfusion with anaerobic ferrous iron solutions for periods of 30 s appeared to be well tolerated by the liver. Nevertheless, to exclude the possibility that our results were in any way affected by the anaerobic period, control experiments were performed in which ferrous iron solutions containing 0.3 mM ascorbate were oxygenated by passage through the lung immediately before they entered the liver. No differences were seen (Table I ). This method was not used routinely because the additional deadspace associated with use of the lung greatly prolonged the time required to reach steady state.
Efficiency of uptake. At low concentrations (1 gM), 63±4% (mean±SEM) of ferrous iron was extracted from tricine buffer in a single pass through the liver (Table I) . Extraction of ferric iron was similar (55±2%, P> 0.1). Addition of0.3 mM ascorbate increased the extraction of ferrous iron slightly (74±2%, P < 0.05), while further addition of 1% albumin slightly reduced it (44±6%, P < 0.0025). These differences could not be explained by variation in the perfusate flow rate (differences not significant). in the presence ofphysiologic coordinating compounds was also highly efficient (Tables II and III) . Similar high extractions were observed from ultrafiltered human serum.
Autoradiography. Fig. 3 shows the distribution of autoradiographic grains over a 0. with an apparent Km of22±5 ;iM (mean±SEM), and an apparent Vm.x of 38±7 nmol * min-' g liver' (Fig. 6 ). Saturation did not result from loss of viability, since similar results were obtained regardless of the order in which the solutions were perfused. Effect of ascorbate. Addition of ascorbate (0,3 mM) to the ferrous iron solutions had little effect on uptake parameters (K., 16±2 hM; V., 32±5 nmol . min-' . g liver-'; P> 0.15 for both).
As previously noted, single-pass extraction increased slightly.
Effect ofalbumin. Addition of bovine albumin (1%) to the ferrous iron solutions containing 0.3 mM ascorbate increased the apparent K. (27±3 jiM, P < 0.01) but did not change the apparent V.. (40±2 nmol . min-. g liver-', P > 0.1). As previously noted, single-pass extraction decreased slightly.
Ferric iron kinetics. Uptake of ferric iron also displayed saturation kinetics (Fig. 7) . The apparent Km was 14±2 AM and the apparent Vmax, 24±2 nmol* min-' g liver-'. These values The fraction of ferrous iron extracted in a single-pass through the liver is shown for a series of solutions containing 1 pM ferrous iron and a physiologic coordinator. All solutions, except ultrafiltered serum, contained Krebs-bicarbonate, and were maintained anaerobic by bubbling with 95% N2/5% CO2. Flow rates were similar to ferrQus tricine experiments (flow rate = 2.55±0.15 ml * min-' g liver-'). Mean values are shown with standard errors. Extraction of iron from all solutions, except that containing albumin, was highly efficient.
were not significantly different from those for ferrous iron or ferrous iron plus ascorbate (P > 0.05).
Discussion
The liver plays a central role in iron metabolism both in normal individuals and in iron-overloaded individuals. Normally, -99% ofthe iron in plasma is bound to transferrin, while the remainder circulates as low molecular weight complexes or in association with other serum proteins such as albumin (6) . Recent studies suggest that hepatic uptake from the transferrin-bound pool involves receptor-mediated endocytosis followed by dissociation ofthe iron from transferrin at the acid pH within the endosome (1-4). The liberated iron (presumably in the form of low molecular weight complexes) is then thought to diffuse across the membrane of the endocytic vesicle into the cytoplasm while the apotransferrin is recycled to the plasma. This process, which appears sensitive to the iron requirements of the animal (13), typically removes <1% of the transferrin from the plasma as it passes through the liver (5).
Much less is known about the mechanism by which the liver removes NTB iron from plasma. Zimelman et al. (5) The fraction of ferric iron extracted in a single-pass through the liver is shown for a series of solutions containing 1 pM ferric iron and a physiologic coordinator. All solutions, except ultrafiltered serum, contained Krebs-bicarbonate, and the pH maintained at 7.4 by bubbling with 95% 02/5% CO2. Flow rates were similar to ferric tricine experiments (flow rate = 3.11±0.17 ml * min-' g liver'). [Fe2+] (,uM) Figure 6 . Uptake of ferrous iron vs. concentration. Both ferrous iron (triangles) and ferrous iron plus 0.3 mM ascorbate (circles) showed saturation. Ascorbate produced no significant difference in the apparent kinetic constants (Table I) . Points represent mean values for at least five experiments, and are shown with 95% confidence intervals.
that rat liver removes NTB iron from the serum of hemochromatotic patients. However, no systematic study of the uptake kinetics for NTB iron has yet appeared. The current data indicate that hepatic removal of low molecular weight NTB iron complexes from serum is a highly efficient process, with 58-75% removed in a single-pass through the liver. Since the flow rate selected for these studies exceeds normal plasma flow by more than threefold, hepatic removal of NTB iron in vivo should be even more complete. Rapid removal of iron from the plasma as it passes through the liver should generate a range of iron concentrations within the hepatic sinusoids, with the periportal hepatocytes exposed to the highest values. In consequence, these hepatocytes would be expected to accumulate the most iron. Periportal iron accumulation is, in fact, characteristic of hemochromatosis (16) soning ( 17) . In contrast, uptake oftransferrin-bound iron appears to be too inefficient to produce lobular concentration gradients (5) and thus cannot account for the observed iron distribution.
These gradients thus suggest that most of the excess hepatic iron in hemochromatosis results from efficient uptake of NTB iron rather than from less efficient uptake of transferrin-bound iron.
Iron is highly toxic to many organ systems, including heart, pancreas, and pituitary ( 16) . While iron can be toxic to the liver as well, toxicity appears to occur at higher tissue concentrations, permitting storage of excess body iron in the liver. We suggest here that an important factor in determining the rate of iron removal by the liver in iron-overloaded states is the degree of saturation of transferrin, since this largely determines the concentration of NTB iron in plasma (9, 18) . If so, the liver may prevent excess absorbed iron from entering the systemic circulation by removing effectively all iron in excess of the binding capacity of transferrin. Indeed, it has been reported that orally absorbed iron in hemochromatosis patients is almost completely removed by the liver before it enters the systemic circulation (19) . Such a mechanism would also explain why hepatic iron loading precedes iron deposition in other tissues (20) .
Extrapolation of our results to in vivo conditions involves several assumptions, most importantly that the iron-tricine complexes studied are representative of the NTB iron pool in plasma. Tricine was selected over naturally occurring coordinating agents for the kinetic studies because it is a nonmetabolized amino acid that binds to, and effectively solubilizes, both ferrous iron and ferric iron (R. Nakon, personal communication). In addition, the buffering capacity of tricine allowed us to omit bicarbonate from the solutions, thus avoiding formation of poorly soluble carbonates at higher concentrations of ferrous iron that would have made interpretation of the data more difficult. Tricine appears to be well-tolerated by the liver, and has been previously used in perfused liver (21) and cell culture (22) studies with minimal toxicity. The only possible toxic effect noted in our study was a slight shrinkage ofthe cells that did not reduce their capacity to remove iron from the perfusate and that was not associated with ultrastructural evidence of toxicity. Thus, while we cannot exclude the possibility that replacement of bicarbonate with tricine had some effect on the results, it seems unlikely.
The availability of tricine-bound iron appears to be similar to that of iron bound to physiologic coordinators. Thus, perfusion with low concentrations of ferrous iron in the presence ofexcess ascorbate or histidine, both important coordinators of ferrous ion in plasma (6) , resulted in comparable rates of extraction (Table II) . Similar rates were seen when ferric iron was coordinated with its physiologic chelators (6) , citrate, fructose, oxalate, and glutamate (Table III) . Most significantly, both ferrous iron and ferric iron were efficiently removed from fresh ultrafiltered serum, which presumably retains normal concentrations of low molecular weight iron-coordinating compounds. Somewhat less ferrous iron was taken up from 4% solutions ofhuman albumin, although extraction would still be relatively efficient at the slower flow rates in vivo. Moreover, only a small proportion of the NTB-iron in plasma is bound to albumin (6) , suggesting that albumin binding should not significantly limit removal of NTB iron when other coordinating agents are present.
Perfusion solutions containing ferrous iron were kept anaerobic to prevent auto-oxidation and generation of potentially toxic oxygen radicals. The brief period of hypoxia necessary to measure uptake from these solutions appears to have been well tolerated by the liver. Indeed, previous studies have shown that the liver is remarkably tolerant of anaerobic conditions providing it is well glycogenated and the products of glycolysis are not allowed to accumulate (23) . Furthermore, 30 s seems to be too brief a period to produce significant changes in intracellular energy metabolism (24) . For all these reasons, the use of anaerobic perfusate solutions seems unlikely to have affected our results.
Uptake was saturable for ferric iron and for ferrous iron with and without added ascorbate. Only small differences in the kinetic parameters were observed for these different forms of iron, suggesting uptake in each case may occur by a common mechanism. Previous studies in other tissues have often found ferrous complexes to be more available for uptake than ferric. We suggest here that these differences may reflect the relative insolubility of most ferric iron complexes (6), since addition of tricine (which solubilizes both ferrous iron and ferric iron) led to similar rates of uptake in each case.
The observed saturation kinetics suggest a membrane carrier system may be involved in the uptake of NTB iron by the liver. However, other possible explanations must be considered. Apparent saturation could result if the iron formed high molecular weight aggregates at higher concentrations that were less available for uptake. However, no differences were seen in the uptake of ferrous and ferric iron, despite the fact that the ferric iron has a much greater tendency to aggregate (6) . Moreover, both forms of iron readily crossed a low molecular weight cut-off dialysis membrane. Finally, addition of ascorbate (which would be expected to reduce aggregation by chelating the iron) had no effect on the observed saturation. Alternatively, apparent saturation could result from deterioration of the liver preparation or saturation of the intracellular iron binding capacity during the course of the experiment. Both ofthese possibilities are excluded by the careful validation of steady-state described previously.
Our data cannot, however, exclude the possibility that saturation resulted from a rate-limiting metabolic process inside the liver (e.g., incorporation ofthe iron into ferritin), rather than a membrane carrier. In this case, the similar kinetic parameters for ferrous and ferric iron could reflect conversion of the iron to a common oxidation state before the rate-limiting process. Studies with membrane vesicles may be necessary to resolve this ambiguity.
Autoradiography showed that the NTB iron was predominantly removed by parenchymal cells, while removal by Kupffer cells appeared quantitatively much less important. This distribution is similar to that seen in hemochromatosis, but differs from that seen in hemosiderosis secondary to transfusional iron overload, in which much more ofthe iron is deposited in Kupffer cells.
The 0.6-1 oM concentration of NTB iron typical of normal plasma (9) is well below that needed to saturate the hepatic removal mechanism (Ki, 14-20 WM), confirming that uptake should be efficient for physiological NTB iron concentrations. The much higher concentrations of NTB iron (typically [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] ,RM) characteristic of iron overload states (9) may reflect not only saturation of serum transferrin, but also reduced hepatic removal ofNTB iron because ofassociated hepatic damage and/ or portosystemic shunting. Thus, the highest levels of NTB iron would be expected in patients whose livers are no longer able to efficiently remove this form of iron from plasma.
In summary, we have described a transport mechanism in the liver that removes low molecular weight iron complexes from plasma with high efficiency. This mechanism can account for both the selective accumulation of iron by the liver in ironoverload states and the periportal distribution commonly observed. The physiologic importance of this transport mechanism remains uncertain. However, it may serve to prevent toxic concentrations of NTB iron from accumulating in the systemic circulation.
